Lycopene and metabolic markers: a narrative review

  • Júlia Carolina Lopes Silva Universidade Federal de Pernambuco, Pernambuco, Brasil.
  • Matheus Luis Cobel de Santana Faculdade de Comunicação Tecnologia e Turismo de Olinda, Pernambuco, Brasil.
  • Sarah Evelin Dias Campos Faculdade de Comunicação Tecnologia e Turismo de Olinda, Pernambuco, Brasil.
  • André dos Santos Costa Universidade Federal de Pernambuco, Pernambuco, Brasil.
  • Jakeline Olindina Francelino Universidade Federal de Pernambuco, Pernambuco, Brasil.
Keywords: Carotenoids, Cholesterol, Lipids, Tomato, Lycopene

Abstract

Objective: to define the action of lycopene under CT, HDL, LDL and TG and to analyze which sufficient dosages have a positive effect on metabolic markers. Methodology: The investigation was based on the effect of products containing lycopene and its effect on serum metabolic markers of total cholesterol, LDL, HDL and triglycerides. For analysis of in vivo studies, studies that met intervention criteria with controlled design, diet or manipulated controlled by crossed or parallel placebo, randomized clinical trial with standardized dosage of lycopene in the treatment and control group and intervention 2≤ weeks that included total cholesterol, HDL, LDL, and triglycerides were included.. Results: It was seen that lycopene plays an important role on metabolic markers, due to its ability to reduce the mechanism of HMG-Coa reductase, decreasing the synthesis of cholesterol and its antioxidant capacity under LDL. Lycopene also modulated the activity of PPAR and LXR, modulating the action of ABCA1, Apoa1 and caveolins, improving HDL synthesis and cholesterol efflux. Dosages with a positive cholesterol effect vary, but are around 26.5 mg of lycopene per day, reported in in vivo studies with cholesterol supplementation. Conclusion: The review suggests the efficacy of lycopene in reducing metabolic markers, thus reducing the risk of atherosclerotic diseases.

References

-Bose, K.S.C.; Agrawal, B.K. Effect of Lycopene from Tomatoes (Cooked) on Plasma Antioxidant Enzymes, Lipid Peroxidation Rate and Lipid Profile in Grade-l Hypertension. Annals of Nutrition and Metabolism. Vol. 51. Num. 5. 2007. p. 477-481.

-Brito, L.F.; Toledo, R.C.L.; Carvalho, I.M.M.; Leite, J.P.V.; Ribeiro, S.M.R.; Peluzio, M.C.G. et al. Produtos Naturais Ativadores de PPAR e Marcadores Associados ao Processo Inflamatório na Síndrome Metabólica. Revista Brasileira Plantas Medicinais. Vol. 15. Num. 3. 2013. p. 449-466.

-Calixto-Lima, L.; Reis, N.T. Interpretação de Exames Laboratoriais Aplicados à Nutrição Clínica. Rio de Janeiro. Rubio. 2012. p. 210.

-Duval, C.; Touche, V.; Tailleux, A.; Fruchart, J.C.; Fievet, C.; Clavey, V. et al. Niemann-Pick C1 Like 1 Gene Expression is Down-Regulated by LXR Activators in the Intestine. Biochemical and Biophysical Research Communications. Vol. 340. Num. 1. 2006. p. 1259-1263.

-Elias, M.B.; Teodoro, A.J.; Oliveira, F.L.; Guma, F.C.R.; Martucci, R.B.; Borojevic, R. Lycopene Inhibiis Hepatic Stellate Cell Activation and Modulates Cellular Lipid Storage and Signaling. Food and Fun. Vol. 1. Num. 1. 2013. p. 1-15.

-Engelhard, Y.N.; Gazer, B.M.D.; Paran, E.M.D. Natural Antioxidants From Tomato Extract Reduce Blood Pressure in Patients With Grade-1 Hypertension: A Double-blind, Placebo-controlled Pilot Study. American Heart Journal. Vol. 151. Num. 1. 2006. p. 100.e1-100.e6

-Eroglu, A.; Harrison, E.H. Carotenoid Metabolism n Mammals, Including Man: Formation, Occurrence, and Function of Apocarotenoids. Journal of Lipid Research. Vol. 54. Num. 1. 2013. p. 1719-1730.

-Ferderbar, S. Modulação da Ativação dos Receptores Ativados por Proliferadores de Peroxissoma (PPAR) e dos Receptores X Hepáticos (LXR) por LNO2. Tese de Doutorado. USP. São Paulo. 2008.

-Fuhrman, B.; Elis, A.; Aviram, M. Hypocholesterolemic Effect of Lycopene an B-Carotene Is Related to Suppression of Cholesterol Syntesis and Augmentation of LDL Receptor Activity in Macrophages. Biochemical and Biophysical Research Communications. Vol. 253. Num. 3. 1997. p. 658-662.

-Gajendragadkar, P.R.; Hubsh, A.; Ma¨ki-Peta¨ja, K.M.; Serg, M.; Wilkinson, I.B.; Cheriyan, J. Effects of Oral Lycopene Supplementation on Vascular Function in Patients with Cardiovascular Disease and Healthy Volunteers: A Randomised Controlled Trial. Plos One. Vol. 9. Num. 6. 2014. p. 1-13.

-Kumar, M.; Rehan, H.S.; Puri, R.; Yadav, M.; Gupta, L.K. Randomized Controlled Trial Comparing the Efficacy of Daily and Every Other Day Atorvastatin Therapy and its Correlation With Serum Hydroxymethylglutaryl-Coa Reductase Enzyme Levels in Naïve Dyslipidemic Patients. Indian Heart Journal. Vol. 70. Num. 3. 2018. p. S64-S67.

-Li, H.; Chen, A.; Zhao, L. et al. Effect of tomato consumption on fasting blood glucose and lipid profiles: A systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research. Vol. 34. Num. 8. 2020. p. 1956-1965.

-Li, Y.P.D.; Chang, Y.B.S.; Huang, H.P.D.; Wu, Y.M.S.; Yang, M.P.D.; Chao, P.P. Tomato Juice Supplementation in Young Women Reduces Inflammatory Adipokine Levels Independently of Body Fat Reduction. Nutrition. Vol. 31. Num. 1. 2015. p. 391-396.

-Lindshield, B.L.; Canene-Adams, K.; Erdman, Jr.J.W. Lycopenoids: Are Lycopene Metabolites Bioactive?. Archives of Biochemistry and Biophysics.Vol. 458. Num. 1. 2007. p. 136-140.

-Ludke, M.C.M.M.; Lopez, J. Colesterol e Composição dos Ácidos Graxos nas Dietas para Humanos e na Carcaça Suína. Rio Grande do Sul. Ciência Rural. Vol. 29. Num. 1. 1999. p. 181-187.

-Min, H.P.D.; Kapoor, A.M.D.; Fuchs, M.M.D.; Mirshahi, F.M.S.; Zhou, H.D.; Kellum, J.M.D. et al. Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism is Associated With the Severity of Nonalcoholic Fatty Liver Disease. Cell Metabolism. Vol. 15. Num. 5. 2012. p. 665-674.

-Misra, R.; Mangi, S.; Joshi, S.; Mittal, S.; Gupta, S.K.; Pandey, R.M. LycoRed as an Alternative to Hormone Replacement Therapy in Lowering Serum Lipids and Oxidative Stress Markers: A Randomized Controlled Clinical Trial. Journal of Obstetrics and Gynaecology Research. Vol. 32. Num. 3. 2006. p. 299-304.

-Moritz, B.; Tramonte, V.L.C. Biodisponibilidade do Licopeno. Revista de Nutrição. Vol. 19. Num. 2. 2006. p. 265-273.

-Napolitano, M.; Pascale, C.; Wheeler-Jones, C.; Botham, K.M.; Bravo, E. Effects of Lycopene on the Induction of Foam Cell Fomation by Modified LDL. American Journal of Physiology-Endocrinology and Metabolism. Vol. 293. Num. 6. 2007. p. 1820-1827.

-Ni, Y.; Zhuge, F.; Nagashimada, M. et al. Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice. Free Radical Biology & Medicine. Vol. 152. Num. 1. 2020. p. 571-582.

-Palozza, P.; Catalano, A.; Simone, R.E; Mele, M.C; Cittadini, A. Effect of Lycopene and Tomato Products on Cholesterol Metabolism. Annals of Nutrition and Metabolism. Vol. 61. Num. 1. 2012. p. 126-134.

-Palozza, P.; Simone, R.; Catalano, A.; Parrone, N.; Monego, G.; Ranelletti, F. Lycopene Regulation of Cholesterol Synthesis and Efflux in Human Macrophages. The Journal of Nutritional Biochemistry. Vol. 22. Num. 10. 2011. p.971-978.

-Petyaev, I.M.; Ziganigirova, N.A.; Tsibezov, V.V.; Morgunova, E.Y.; Bondareva, N.E.; Kyle, N.H. et al. Association With Monoclonal Antibody Promotes Intracellular Delivery of Licopene. Monoclon Antib Immunodiagn Immunother. Vol. 37. Num. 3. 2018. p. 1-6.

-Ried, K.; Fakler, P. Protective Effect of Lycopene on Serum Cholesterol and Blood Pressure: Meta-analyses of Intervention Trials. Maturitas. Vol. 68. Num. 4. 2011. p. 299-310.

-Sato, Y.; Watanabe, R.; Uchiyama, N.; Ozawa, N.; Takahashi, Y.; Shirai, R. Inhibitory Effects of Vasostatin-1 Against Atherogenesis. Clinical Science. Vol. 132. Num. 23. 2018. p. 2493-2507.

-Shen, Y.; Chen, S.; Wang, K. Contribution of Tomato Phenolics to Antioxidant and Down-regulation of Blood Lipids. Journal of Agricultural and Food Chemistry. Vol. 55. Num. 1. 2007. p. 6475-6481.

-Silaste, M.; Alfthan, G.; Aro, A.; Kesaniemi, A.; Horkko, S. Tomato Juice Decreases LDL Cholesterol Levels and Increases LDL Resistance to Oxidation. British Journal of Nutrition. Vol. 98. Num. 1. 2007. p. 1251-1258.

-Simões, K.; Magosso, R.F.; Lagoeiro, C.G.; Castellan, V.T.; Silva, N.S.; Scrivante, B.F. et al. Ação do Licopeno nos Musculos Esqueletico e Cardiaco Sob Estresse Oxidativo por Exercicios. Revista Brasileira de Medicina do Esporte. Vol. 20. Num. 2. 2014. p. 105-109.

-Tallarida, R.J. Receptor Discrimination and Control of Agonist-antagonist Binding. APS. American Physiological Society Journal. Vol. 296. Num. 2pt1. 1995. p. E379-E391.

-Tavares, V.; Hidrata, M.H.; Hidrata, R.D.C. Receptor Ativo por Proliferadores de Peroxissoma Gama (PPARy): Estudo Molecular na Homeostase da Glicose, Metabolismo de Lipídios e Abordagem Terapêutica. Arquivos Brasileiros de Endocrinologia Metabologia. Vol. 51. Num. 5. 2007. p. 526-533.

-Tierney, A.C.; Rumble, C.E.; Billings, L.M.; George, E.S. Effect of Dietary and Supplemental Lycopene on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis. Advances in Nutrition. Vol. 11. Num. 6. 2020. p. 2453-1488.

-Trindade, M.; Martucci, R.B. Efeitos do Licopeno na Saude Cardivascular. Revista do Hospital Universitário Pedro Ernesto. Vol. 10. Num. 3. 2011. p. 67-73.

-Tstisimpikou, D.; Tsarouhas, K.; Kioukia-Fougia, N.; Skondra, C.; Fragkiadaki, P.; Papalexis, P. Dietary Supplementation With Tomate-Juice in Patients With Metaolic Syndrome: A Suggestion to Alleviate Detrimental Clinical Factors. Food and Chemical Toxicology. Vol. 74. Num. 1. 2014. p. 9-13.

-Uenojo, M.; Junior, M.R.M.; Pastore, G.M. Carotenóides: Propriedades, Aplicações e Biotransformação para Formação de Compostos de Aroma. Química Nova. Vol. 30. Num. 3. 2007. p. 616-622.

-Visioli, F.; Riso, P.; Grande, S.; Galli, C.; Porrini, M. Protective Activity of Tomato Products on In vivo Markers of Lipid Oxidation. European Journal of Nutrition. Vol. 42. Num. 1. 2003. p. 201-206.

-Yang, C.; Lu, I.; Chen, H.; Hu, M. Lycopene Inhibits the Proliferation of Androgen-dependent Human Prostate Tumor Cells Through Activation of PPAR-LXR-ABCA1 Pathway. The Journal of Nutritional Biochemistry. Vol. 23. Num. 1. 2012. p. 8-17.

-Zhang, P.; Li, J.; Li, M.; Sui, Y.; Zhou, Y.; Sun, Y. Effects of lycopene on metabolism of glycolipid and inflammation in non-alcoholic fatty liver disease rats. Wei Sheng Yan Jiu. Vol. 49. Num. 2. 2020. p. 254-271.

-Zhu, Y.; Liu, R.; Shen, Z.; Cai, G. Combination of luteolin and lycopene effectively protect against the "two-hit" in NAFLD through Sirt1/AMPK signal pathway. Life Sciences. Vol. 256. Num. 1. 2020. p. 1-12.

-Zou, J.; Feng, D. Lycopene Reduces Cholesterol Absorption Through the Downregulation of Niemann-Pick C1-like 1 in Caco-2 Cells. Mol. Molecular Nutrition & Food Research. Vol. 59. Num. 1. 2015. p. 2225-2230.

Published
2022-08-06
How to Cite
Silva, J. C. L., Santana, M. L. C. de, Campos, S. E. D., Costa, A. dos S., & Francelino, J. O. (2022). Lycopene and metabolic markers: a narrative review. Brazilian Journal of Obesity, Nutrition and Weight Loss, 15(98), 1373-1385. Retrieved from https://www.rbone.com.br/index.php/rbone/article/view/1564
Section
Scientific Articles - Review